chartexchange

Xeris Biopharma Holdings Inc Reports Q3 2026 EPS of $0.06, Revenue Misses Estimates at $107. ...

GuruFocus | Nov 5, 2026 7:34 AM EST

Recorlev Growth and Raised Guidance Offset a Gvoke Gross-to-Net Adjustment Related Stocks: XERS ,

Read original article